Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies

Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies

US Patent 11428694 · Granted Aug 30, 2022

Estimated economic value: $305,810,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Assays for detecting SARS-CoV-22024
Anti-GP73 monoclonal antibodies and methods of obtaining the same2022
Anti-GP73 monoclonal antibodies and methods of obtaining the same2022
Anti-GP73 monoclonal antibodies and methods of obtaining the same2022
Subject anti-HCV antibody detection assays employing NS3 capture peptides2022
Subject anti-HCV antibody detection assays employing NS3 capture peptides2020
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2019
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2019
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2019
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2019
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2019
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2019